Arvinas, Inc. (ARVN)

NASDAQ: ARVN · Real-Time Price · USD

7.02

-0.61 (-7.99%)

May 6, 2025, 3:05 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Protein Degradation Therapies	263.40M	Log In	Log In	Log In	Log In	Upgrade
Protein Degradation Therapies Growth	235.54%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	263.40M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	235.54%	Log In	Log In	Log In	Log In	Upgrade